Daniel Zingg
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Viral Infectious Diseases and Gene Expression in Insects 5
- PI3K/AKT/mTOR signaling in cancer 5
- Epigenetics and DNA Methylation 4
- Insect Resistance and Genetics 3
- Co-authors
- Lukas Sommer (9 shared papers)Onur Boyman (3 shared papers)Natalia Arenas-Ramirez (3 shared papers)Reinhard Dummer (7 shared papers)Mitchell P. Levesque (6 shared papers)Phil F. Cheng (5 shared papers)Rodney Alexander Rosalia (1 shared paper)Stephan Bodis (5 shared papers)
- Journals
- Journal of Bacteriology (2 papers)Cancer Research (2 papers)Cell stem cell (1 paper)Molecular Cancer Therapeutics (1 paper)Oncogene (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Daniel Zingg
32 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Oncology 441
- Immunology 341
- Cancer Research 218
- Molecular Biology 965
- Cell Biology 126
Countries citing papers authored by Daniel Zingg
This map shows the geographic impact of Daniel Zingg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Zingg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Zingg more than expected).
Fields of papers citing papers by Daniel Zingg
This network shows the impact of papers produced by Daniel Zingg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Zingg. The network helps show where Daniel Zingg may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Zingg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 261 | |
| 2 | 2017 | 247 | |
| 3 | 2012 | 195 | |
| 4 | 2017 | 133 | |
| 5 | 2016 | 106 | |
| 6 | 2018 | 101 | |
| 7 | 2015 | 76 | |
| 8 | 2015 | 67 | |
| 9 | 2004 | 64 | |
| 10 | The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C. | 2001 | 63 |
| 11 | 2019 | 49 | |
| 12 | 2004 | 48 | |
| 13 | 2013 | 43 | |
| 14 | 2007 | 41 | |
| 15 | 2001 | 40 | |
| 16 | 2019 | 37 | |
| 17 | 2011 | 19 | |
| 18 | Madex Plus and Madex I12 overcome Virus Resistance of Codling Moth | 2008 | 18 |
| 19 | 2004 | 12 | |
| 20 | 2020 | 9 |
About Daniel Zingg
Daniel Zingg is a scholar working on Molecular Biology, Plant Science, Insect Science, Oncology and Cancer Research, having authored 35 papers that have together received 1.7k indexed citations. Recurring topics across this work include Forest Insect Ecology and Management (5 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Genomics and Diagnostics (4 papers), Epigenetics and DNA Methylation (4 papers), Insect Pheromone Research and Control (3 papers), Insect Resistance and Genetics (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Oncology (441 citations), Immunology (341 citations), Cancer Research (218 citations), Molecular Biology (965 citations) and Cell Biology (126 citations). Daniel Zingg has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Lukas Sommer, Onur Boyman, Natalia Arenas-Ramirez, Reinhard Dummer, Mitchell P. Levesque, Phil F. Cheng, Rodney Alexander Rosalia, Stephan Bodis, Dilara Şahin and Martin Pruschy. Their work appears in journals such as Journal of Bacteriology, Cancer Research, Cell stem cell, Molecular Cancer Therapeutics and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.